Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Tar... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
0
Authors
Mark Middleton
18 more
Mark Middleton
•
Cheryl McAlpine
16 more
•
Mario Sznol
Published
August 18, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Cancer Research
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1158/1078-0432.ccr-20-1247
